. 
Experimental details
Carbon-bound H atoms were placed in calculated positions (C-H 0.93 Å) and were included in the re nement in the riding model approximation, with U iso (H) set to 1.2Ueq(C). The nitrogen-bound H atoms was located on a di erence Fourier map and re ned freely.
Discussion
Adamantane derivatives were early known for their diverse pharmacological activities [1] . Several adamantyl-bearing analogues are currently employed as potent medications for the control of viral infections [2] [3] [4] [5] , hyperglycemia [6] and central nervous disorders [7, 8] . In addition, numerous adamantane derivatives were reported to exhibit potent anticancer [9, 10] , bactericidal, fungicidal [11, 12] and antimalarial [13] activities. Moreover, various N-(1-and 2-adamantyl)carboxamides and N-(substituted)carbothioamides were reported to display diverse pharmacological activities [14] [15] [16] [17] . As a part of our ongoing research interest in the chemotherapeutic [18] [19] [20] [21] and structural [22, 23] properties of adamantane derivatives, we recently reported the synthesis, antibacterial and hypoglycemic activities of the title compound [21] , and we report herein its crystal structure. The crystal structure of the title compound, C17H 22 N 2 S, contains one molecule in the asymmetric unit. All bond lengths and angles are in the expected ranges. The central piprazine ring (N2-C12-C13-N3-C14-C15) has the typical chair conformation. In the crystal structure, molecules are connected at least by one intermolecular hydrogen bond, of which S1 works as hydrogen bond acceptor and C5 works as hydrogen bond donor (Symmetry code: −x+3/2, y−1/2, z).
The NH group (N1) is not involved in any hydrogen bonding interaction, as this group is shielded by two adjacent CH 2 groups.
